IPO registrations (S-1, F-1) · Registrants
ARGOS THERAPEUTICS INC
- SEC CIK
- 1105533 · filings on EDGAR ↗
- Former names
- MERIX BIOSCIENCE INC (2004–2004)
- Registration
- Form S-1, first filed 2011-07-29, last 2014-02-06; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2014-02-07; declared effective 2014-02-06; withdrawal requested 2012-03-06
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 4233 TECHNOLOGY DR, Durham, NC 27704
- EIN
- 56-2110007
- EDGAR entity type
- operating
- Insiders and CEO pay
- ARGOS THERAPEUTICS INC on the corporate pages
Offering terms
- Final price
- $8.00 per share (424B4 filed 2014-02-07, an initial public offering)
- Shares sold
- 5,625,000
- Gross proceeds
- $45,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ARGS
- Lead underwriters
- Piper Sandler
- Syndicate
- Stifel; JMP Securities; Needham & Company
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ARGOS THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ARGOS THERAPEUTICS, INC EXACT (EIN (EXACT))
- Federal award recipient: ARGOS THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: ARGOS THERAPEUTICS INC EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-07-29 | S-1 | S-1 (registration) | ARGOS THERAPEUTICS INC | 0001193125-11-202087 ↗ |
| 2011-09-02 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-11-240293 ↗ |
| 2011-10-19 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-11-275003 ↗ |
| 2012-01-06 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-12-005378 ↗ |
| 2012-02-10 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-12-052505 ↗ |
| 2012-02-16 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-12-064248 ↗ |
| 2012-03-06 | RW | RW (withdrawal request) | ARGOS THERAPEUTICS INC | 0001193125-12-099093 ↗ |
| 2013-12-30 | S-1 | S-1 (registration) | ARGOS THERAPEUTICS INC | 0001193125-13-488018 ↗ |
| 2014-01-21 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-14-015120 ↗ |
| 2014-02-04 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-14-034906 ↗ |
| 2014-02-06 | S-1/A | S-1/A (amendment) | ARGOS THERAPEUTICS INC | 0001193125-14-038538 ↗ |
| 2014-02-06 | EFFECT | EFFECT (declared effective) | ARGOS THERAPEUTICS INC | 9999999995-14-000355 ↗ |
| 2014-02-07 | 424B4 | 424B4 (final prospectus) | ARGOS THERAPEUTICS INC | 0001193125-14-040941 ↗ |
| 2015-05-14 | EFFECT | EFFECT (declared effective) | ARGOS THERAPEUTICS INC | 9999999995-15-001356 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-02-06 | S-1/A | registration statement | $0.01 | - | - | 0 | primary document; price line | document ↗ | ||
| 2014-02-07 | 424B4 | final prospectus | $8.00 | 5,625,000 | $45,000,000 | Nasdaq ARGS | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Abbey Jeffrey D | Director,Officer | CEO; Chief Executive Officer; President, CEO | 19 | 2014–2018 | |
| AURORA VENTURES II LLC | TenPercentOwner | 1 | 2014 | ||
| AV II Argos Enrichment, LLC | TenPercentOwner | 1 | 2014 | ||
| Birner Hubert | Director; Director,TenPercentOwner | 11 | 2014–2017 | ||
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | TenPercentOwner | 1 | 2014 | ||
| Cooperatieve AAC LS U.A. | TenPercentOwner | 2 | 2014 | ||
| Fischer Stefan | TenPercentOwner | 1 | 2014 | ||
| Forbion Co-Investment II Cooperatief U.A. | TenPercentOwner | 2 | 2014 | ||
| Goll Alexandra | TenPercentOwner | 1 | 2014 | ||
| Green Cross Corp. | TenPercentOwner | 1 | 2014 | ||
| GRYSKA DAVID W | Director | 1 | 2014 | ||
| HARBINGER AURORA QP VENTURE FUND LLC | TenPercentOwner | 1 | 2014 | ||
| HARBINGER AURORA VENTURE FUND LLC | TenPercentOwner | 1 | 2014 | ||
| Harrelson Lori R. | Officer | Vice President Finance; Vice President of Finance | 12 | 2014–2018 | |
| INTERSOUTH AFFILIATES V LP | TenPercentOwner | 1 | 2014 | ||
| INTERSOUTH PARTNERS IV LP /NC | TenPercentOwner | 1 | 2014 | ||
| Intersouth Partners V, L.P. | TenPercentOwner | 1 | 2014 | ||
| JAIC USSII No. 1, LLC | TenPercentOwner | 1 | 2014 | ||
| Joint Stock Co Pharmstandard | TenPercentOwner | 16 | 2014–2017 | ||
| Kyowa Hakko Kirin Co Ltd | TenPercentOwner | 1 | 2014 | ||
| Lamarre Jean | Director | 3 | 2014–2015 | ||
| LCC Legacy Holdings Inc. | TenPercentOwner | 1 | 2014 | ||
| LUMIRA CAPITAL I LIMITED PARTNERSHIP | TenPercentOwner | 1 | 2014 | ||
| Lumira Capital I Quebec Limited Partnership | TenPercentOwner | 1 | 2014 | ||
| MIESOWICZ FREDERICK | Officer | COO | 6 | 2014–2016 | |
| Mizuho Capital No. 3 Limited Partnership | TenPercentOwner | 1 | 2014 | ||
| Morningside Venture Investments Ltd | TenPercentOwner | 1 | 2014 | ||
| Nicolette Charles A. | Officer | Chief Science Officer; Chief Scientific Officer; CSO; CSO and Vice President of R&D | 14 | 2014–2018 | |
| Petrov Andrei Vladimirovich | Director; Director,TenPercentOwner | 7 | 2014–2016 | ||
| Pharmstandard International S.A. | TenPercentOwner | 16 | 2014–2017 | ||
| Plessinger Douglas C. | Officer | See Remarks | 3 | 2014–2015 | |
| Polack Axel | TenPercentOwner | 1 | 2014 | ||
| Striker Asia Opportunities Fund Corp | TenPercentOwner | 1 | 2014 | ||
| TFG USA, LLC | TenPercentOwner | 1 | 2014 | ||
| TVM V LIFE SCIENCE VENTURES GMBH & CO KG | TenPercentOwner | 1 | 2014 | ||
| TVM V Life Science Ventures Management GmbH & Co. KG | TenPercentOwner | 1 | 2014 | ||
| Underdown Brian J. | Director; Director,TenPercentOwner | 4 | 2014–2015 | ||
| van Deventer Sander | Director; Director,TenPercentOwner | 12 | 2014–2017 | ||
| Vinogradov Alexey Alexandrovich | Director; Director,TenPercentOwner | 5 | 2014–2016 | ||
| Van Holle Philippe Marie Marcel Joseph | Director | 11 | 2014–2016 | ||
| Winterbottom Joan | Officer | Chief Human Resource Officer; Chief Human Resources Officer | 9 | 2015–2017 | |
| Carey Robert | Director | 7 | 2015–2017 | ||
| ALLEN LEE F MD PhD | Officer | Chief Medical Officer | 5 | 2016–2017 | |
| ForArgos B.V. | TenPercentOwner | 3 | 2016 | ||
| Krol Igor | Director | 6 | 2016–2017 | ||
| Katz Richard D | Officer | Vice President and CFO; VP and Chief Financial Officer; VP & Chief Financial Officer | 9 | 2016–2018 | |
| SNYDERMAN RALPH | Director | 3 | 2016–2017 | ||
| Mtibelishvily Irackly | Director | 3 | 2016–2017 | ||
| MORRISON RICHARD G | Director | 2 | 2017 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ARGOS THERAPEUTICS, INC. | NC | State business registries | name and state |
| Plan sponsor | ARGOS THERAPEUTICS, INC | NC | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | ARGOS THERAPEUTICS, INC. | NC | Federal spending (USAspending) | name and state |
| Patent assignee | Argos Therapeutics, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | ARGOS THERAPEUTICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Argos Therapeutics, Inc. | NC | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ARGOS THERAPEUTICS, INC | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
- CURAXIS PHARMACEUTICAL Corp NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health